Skip to content
Screener

Bio-Rad Laboratories BIO Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Danaher logo
DanaherDHR
$1.3B+8.3%
MaxCyte logo
MaxCyteMXCT
$1.37M+7.7%
Quanterix Corporation logo
Quanterix CorporationQTRX
$7.81M+51.6%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$31.8M+6.0%
Agilent Technologies logo
Agilent TechnologiesA
$187M-1.1%
TEC
Bio-TechneTECH
$14.18M+0.9%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.42B+31.8%
Enterprise value$9.9B+20.9%
P/E55.8×+33.4×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
LIABILITIES AND STOCKHOLDERS’ EQUITYMarch 31, 2026 / (Unaudited)December 31, 2025
Accrued payroll and employee benefits148.4172.3
Current maturities of long-term debt and notes payable400.51.3
Income and other taxes payable44.936.6
Current operating lease liabilities36.236.1
Other current liabilities153.9141.7
Total current liabilities917.0517.0
Long-term debt, net of current maturities802.91,201.7
Deferred income taxes881.81,059.4

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's operating lease liabilities (current)?
Bio-Rad Laboratories (BIO) reported operating lease liabilities (current) of $36.2M in Q1 2026.
How has Bio-Rad Laboratories's operating lease liabilities (current) changed year-over-year?
Bio-Rad Laboratories's operating lease liabilities (current) decreased by 12.3% year-over-year, from $41.3M to $36.2M.
What is the long-term trend for Bio-Rad Laboratories's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Bio-Rad Laboratories's operating lease liabilities (current) has grown at a -0.2% compound annual growth rate (CAGR), from $36.51M to $36.1M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Bio-Rad Laboratories's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude